New Jersey § 26:2L-2 Legislative findings and declarations

New Jersey Statutes

§ 26:2L-2 — Legislative findings and declarations

New Jersey § 26:2L-2

Title 26HEALTH AND VITAL STATISTICS

This text of New Jersey § 26:2L-2 (Legislative findings and declarations) is published on Counsel Stack Legal Research, covering New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

N.J. Stat. Ann. § 26:2L-2 (2026).

Text

The Legislature finds and declares that recent medical research has shown that the therapeutic use of certain Schedule I controlled dangerous substances may alleviate the nausea and ill-effects of certain medical treatment, such as cancer chemotherapy, and, additionally, may alleviate the ill-effects of certain diseases, such as glaucoma. The Legislature further recognizes that there is a need for further therapeutic research with regard to the use of such controlled dangerous substances for these purposes under strictly controlled circumstances. It is for this purpose that the "Controlled Dangerous Substances Therapeutic Research Act" is hereby enacted. L.1981, c. 72, s. 2, eff. March 23, 1981.

Free access — add to your briefcase to read the full text and ask questions with AI

The Legislature finds and declares that recent medical research has shown that the therapeutic use of certain Schedule I controlled dangerous substances may alleviate the nausea and ill-effects of certain medical treatment, such as cancer chemotherapy, and, additionally, may alleviate the ill-effects of certain diseases, such as glaucoma. The Legislature further recognizes that there is a need for further therapeutic research with regard to the use of such controlled dangerous substances for these purposes under strictly controlled circumstances. It is for this purpose that the "Controlled Dangerous Substances Therapeutic Research Act" is hereby enacted. L.1981, c. 72, s. 2, eff. March 23, 1981.